Medical Care

Global Cell-Based Multiplex Assays Market Research Report 2025

The global market for Cell-Based Multiplex Assays was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell-Based Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell-Based Multiplex Assays include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies, Bio-Techne Corporation, Shimadzu Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Multiplex Assays.
The Cell-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Abcam
Merck
Meso Scale Diagnostics
Promega Corporation
Siemens Healthineers
Boster Biological Technology
Segment by Type
Flow Cytometry
Fluorescence Detection
Multiplex Real-Time PCR
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Multiplex Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Multiplex Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Flow Cytometry
1.2.3 Fluorescence Detection
1.2.4 Multiplex Real-Time PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell-Based Multiplex Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Multiplex Assays Market Perspective (2020-2031)
2.2 Global Cell-Based Multiplex Assays Growth Trends by Region
2.2.1 Global Cell-Based Multiplex Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell-Based Multiplex Assays Historic Market Size by Region (2020-2025)
2.2.3 Cell-Based Multiplex Assays Forecasted Market Size by Region (2026-2031)
2.3 Cell-Based Multiplex Assays Market Dynamics
2.3.1 Cell-Based Multiplex Assays Industry Trends
2.3.2 Cell-Based Multiplex Assays Market Drivers
2.3.3 Cell-Based Multiplex Assays Market Challenges
2.3.4 Cell-Based Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Cell-Based Multiplex Assays Players by Revenue (2020-2025)
3.1.2 Global Cell-Based Multiplex Assays Revenue Market Share by Players (2020-2025)
3.2 Global Cell-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell-Based Multiplex Assays Revenue
3.4 Global Cell-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Cell-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Multiplex Assays Revenue in 2024
3.5 Global Key Players of Cell-Based Multiplex Assays Head office and Area Served
3.6 Global Key Players of Cell-Based Multiplex Assays, Product and Application
3.7 Global Key Players of Cell-Based Multiplex Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Multiplex Assays Breakdown Data by Type
4.1 Global Cell-Based Multiplex Assays Historic Market Size by Type (2020-2025)
4.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2026-2031)
5 Cell-Based Multiplex Assays Breakdown Data by Application
5.1 Global Cell-Based Multiplex Assays Historic Market Size by Application (2020-2025)
5.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell-Based Multiplex Assays Market Size (2020-2031)
6.2 North America Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell-Based Multiplex Assays Market Size by Country (2020-2025)
6.4 North America Cell-Based Multiplex Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Based Multiplex Assays Market Size (2020-2031)
7.2 Europe Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell-Based Multiplex Assays Market Size by Country (2020-2025)
7.4 Europe Cell-Based Multiplex Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Multiplex Assays Market Size (2020-2031)
8.2 Asia-Pacific Cell-Based Multiplex Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Based Multiplex Assays Market Size (2020-2031)
9.2 Latin America Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell-Based Multiplex Assays Market Size by Country (2020-2025)
9.4 Latin America Cell-Based Multiplex Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Multiplex Assays Market Size (2020-2031)
10.2 Middle East & Africa Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell-Based Multiplex Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Cell-Based Multiplex Assays Introduction
11.2.4 R&D Systems Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.2.5 R&D Systems Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Cell-Based Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Protavio
11.4.1 Protavio Company Details
11.4.2 Protavio Business Overview
11.4.3 Protavio Cell-Based Multiplex Assays Introduction
11.4.4 Protavio Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.4.5 Protavio Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Cell-Based Multiplex Assays Introduction
11.5.4 Illumina Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.5.5 Illumina Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Cell-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.6.5 BD Recent Development
11.7 Luminex Corporation
11.7.1 Luminex Corporation Company Details
11.7.2 Luminex Corporation Business Overview
11.7.3 Luminex Corporation Cell-Based Multiplex Assays Introduction
11.7.4 Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.7.5 Luminex Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cell-Based Multiplex Assays Introduction
11.8.4 Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Details
11.9.2 Bio-Techne Corporation Business Overview
11.9.3 Bio-Techne Corporation Cell-Based Multiplex Assays Introduction
11.9.4 Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.9.5 Bio-Techne Corporation Recent Development
11.10 Shimadzu Biotech
11.10.1 Shimadzu Biotech Company Details
11.10.2 Shimadzu Biotech Business Overview
11.10.3 Shimadzu Biotech Cell-Based Multiplex Assays Introduction
11.10.4 Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.10.5 Shimadzu Biotech Recent Development
11.11 Abcam
11.11.1 Abcam Company Details
11.11.2 Abcam Business Overview
11.11.3 Abcam Cell-Based Multiplex Assays Introduction
11.11.4 Abcam Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.11.5 Abcam Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Cell-Based Multiplex Assays Introduction
11.12.4 Merck Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Meso Scale Diagnostics
11.13.1 Meso Scale Diagnostics Company Details
11.13.2 Meso Scale Diagnostics Business Overview
11.13.3 Meso Scale Diagnostics Cell-Based Multiplex Assays Introduction
11.13.4 Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.13.5 Meso Scale Diagnostics Recent Development
11.14 Promega Corporation
11.14.1 Promega Corporation Company Details
11.14.2 Promega Corporation Business Overview
11.14.3 Promega Corporation Cell-Based Multiplex Assays Introduction
11.14.4 Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.14.5 Promega Corporation Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Details
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Cell-Based Multiplex Assays Introduction
11.15.4 Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.15.5 Siemens Healthineers Recent Development
11.16 Boster Biological Technology
11.16.1 Boster Biological Technology Company Details
11.16.2 Boster Biological Technology Business Overview
11.16.3 Boster Biological Technology Cell-Based Multiplex Assays Introduction
11.16.4 Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2020-2025)
11.16.5 Boster Biological Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell-Based Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Fluorescence Detection
Table 4. Key Players of Multiplex Real-Time PCR
Table 5. Key Players of Others
Table 6. Global Cell-Based Multiplex Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cell-Based Multiplex Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cell-Based Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cell-Based Multiplex Assays Market Share by Region (2020-2025)
Table 10. Global Cell-Based Multiplex Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cell-Based Multiplex Assays Market Share by Region (2026-2031)
Table 12. Cell-Based Multiplex Assays Market Trends
Table 13. Cell-Based Multiplex Assays Market Drivers
Table 14. Cell-Based Multiplex Assays Market Challenges
Table 15. Cell-Based Multiplex Assays Market Restraints
Table 16. Global Cell-Based Multiplex Assays Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cell-Based Multiplex Assays Market Share by Players (2020-2025)
Table 18. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2024)
Table 19. Ranking of Global Top Cell-Based Multiplex Assays Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cell-Based Multiplex Assays Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cell-Based Multiplex Assays, Headquarters and Area Served
Table 22. Global Key Players of Cell-Based Multiplex Assays, Product and Application
Table 23. Global Key Players of Cell-Based Multiplex Assays, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cell-Based Multiplex Assays Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2020-2025)
Table 27. Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2026-2031)
Table 29. Global Cell-Based Multiplex Assays Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2020-2025)
Table 31. Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2026-2031)
Table 33. North America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cell-Based Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Details
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Cell-Based Multiplex Assays Product
Table 51. Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. R&D Systems Company Details
Table 54. R&D Systems Business Overview
Table 55. R&D Systems Cell-Based Multiplex Assays Product
Table 56. R&D Systems Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 57. R&D Systems Recent Development
Table 58. Bio-Rad Laboratories Company Details
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Cell-Based Multiplex Assays Product
Table 61. Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Protavio Company Details
Table 64. Protavio Business Overview
Table 65. Protavio Cell-Based Multiplex Assays Product
Table 66. Protavio Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 67. Protavio Recent Development
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina Cell-Based Multiplex Assays Product
Table 71. Illumina Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. BD Company Details
Table 74. BD Business Overview
Table 75. BD Cell-Based Multiplex Assays Product
Table 76. BD Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 77. BD Recent Development
Table 78. Luminex Corporation Company Details
Table 79. Luminex Corporation Business Overview
Table 80. Luminex Corporation Cell-Based Multiplex Assays Product
Table 81. Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 82. Luminex Corporation Recent Development
Table 83. Agilent Technologies Company Details
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies Cell-Based Multiplex Assays Product
Table 86. Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 87. Agilent Technologies Recent Development
Table 88. Bio-Techne Corporation Company Details
Table 89. Bio-Techne Corporation Business Overview
Table 90. Bio-Techne Corporation Cell-Based Multiplex Assays Product
Table 91. Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 92. Bio-Techne Corporation Recent Development
Table 93. Shimadzu Biotech Company Details
Table 94. Shimadzu Biotech Business Overview
Table 95. Shimadzu Biotech Cell-Based Multiplex Assays Product
Table 96. Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 97. Shimadzu Biotech Recent Development
Table 98. Abcam Company Details
Table 99. Abcam Business Overview
Table 100. Abcam Cell-Based Multiplex Assays Product
Table 101. Abcam Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 102. Abcam Recent Development
Table 103. Merck Company Details
Table 104. Merck Business Overview
Table 105. Merck Cell-Based Multiplex Assays Product
Table 106. Merck Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 107. Merck Recent Development
Table 108. Meso Scale Diagnostics Company Details
Table 109. Meso Scale Diagnostics Business Overview
Table 110. Meso Scale Diagnostics Cell-Based Multiplex Assays Product
Table 111. Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 112. Meso Scale Diagnostics Recent Development
Table 113. Promega Corporation Company Details
Table 114. Promega Corporation Business Overview
Table 115. Promega Corporation Cell-Based Multiplex Assays Product
Table 116. Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 117. Promega Corporation Recent Development
Table 118. Siemens Healthineers Company Details
Table 119. Siemens Healthineers Business Overview
Table 120. Siemens Healthineers Cell-Based Multiplex Assays Product
Table 121. Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 122. Siemens Healthineers Recent Development
Table 123. Boster Biological Technology Company Details
Table 124. Boster Biological Technology Business Overview
Table 125. Boster Biological Technology Cell-Based Multiplex Assays Product
Table 126. Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)
Table 127. Boster Biological Technology Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Cell-Based Multiplex Assays Picture
Figure 2. Global Cell-Based Multiplex Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell-Based Multiplex Assays Market Share by Type: 2024 VS 2031
Figure 4. Flow Cytometry Features
Figure 5. Fluorescence Detection Features
Figure 6. Multiplex Real-Time PCR Features
Figure 7. Others Features
Figure 8. Global Cell-Based Multiplex Assays Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cell-Based Multiplex Assays Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical & Biotechnology Companies Case Studies
Figure 11. Hospitals & Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Cell-Based Multiplex Assays Report Years Considered
Figure 14. Global Cell-Based Multiplex Assays Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell-Based Multiplex Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell-Based Multiplex Assays Market Share by Region: 2024 VS 2031
Figure 17. Global Cell-Based Multiplex Assays Market Share by Players in 2024
Figure 18. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell-Based Multiplex Assays Revenue in 2024
Figure 20. North America Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell-Based Multiplex Assays Market Share by Country (2020-2031)
Figure 22. United States Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell-Based Multiplex Assays Market Share by Country (2020-2031)
Figure 26. Germany Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell-Based Multiplex Assays Market Share by Region (2020-2031)
Figure 34. China Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell-Based Multiplex Assays Market Share by Country (2020-2031)
Figure 42. Mexico Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell-Based Multiplex Assays Market Share by Country (2020-2031)
Figure 46. Turkey Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 50. R&D Systems Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 52. Protavio Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 54. BD Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 55. Luminex Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 56. Agilent Technologies Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 57. Bio-Techne Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 58. Shimadzu Biotech Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 59. Abcam Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 60. Merck Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 61. Meso Scale Diagnostics Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 62. Promega Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 63. Siemens Healthineers Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 64. Boster Biological Technology Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies